Goji D.C. (Limited) Cannabis Seeds

Breeder: Moxie Female Seeds

1st Place at High Times Medical Cannabis Cup for CBD concentrate. Sedative effects, anti-inflammatory relief, medium yields, 8-10 weeks flowering time.

$7.47

Goji D.C. (Limited) is currently This product is currently not available.

Goji D.C. (Limited) Cannabis Seeds from Moxie Female Seeds

Goji DC is a CBD balanced strain that took 1st Place at the High Times Medical Cannabis Cup in the San Francisco in 2015 for CBD concentrate. The perfect blend of sedative effects combined with the anti-inflammatory relief of the CBD creates a true winner. Never sacrificing flavor for efficacy, this strain is a patients dream. Ratios can range from 2:1 to 1:1 with either cannabinoid being the dominant. This creates for wide array of complex treatment options. She can be difficult to cultivate and yields and flowering time will depend on the phenotype. A must have strain for any CBD enthusiast.

Goji x ACDC
8-10 Weeks
Medium Yields
Indica Dom Hybrid

Strain FAQ

Where do high CBD strains stand legally?

The legality of high CBD strains can be confusing. Local restrictions differ, with some favouring strains with a specified CBD-to-THC ratio. Most commonly there is a maximum allowed THC percentage of something like 0.2% and as long as the strain does not produce more than this, it is seen as legal. This patchwork of restrictions is creating a confusing but promising CBD-rich product industry.

Why are low-THC strains reportedly better for some people?

Low-THC strains are quickly gaining popularity in the cannabis world due to their lack of psychoactive effects. As the world gradually increases cannabis legality and the potential benefits of the plant are more researched, we are quickly learning that there is much more to cannabis than the representation we see in old movies. Low THC strains are reportedly providing a way for the potential benefits of cannabis to be felt by a greater number of people.

How will cannabis therapy evolve?

With so many strains and pharmacological characteristics, personalised cannabis treatment has a bright future. Patients and doctors will likely soon be able to choose strains that are said to target their ailments, enabling more personalised cannabis therapy.